- Home
- ALCE vs TTNP Comparison
ALCE vs TTNP Comparison
Compare ALCE & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- TTNP
- Stock Information
- Founded
- ALCE 2019
- TTNP 1991
- Country
- ALCE United States
- TTNP United States
- Employees
- ALCE N/A
- TTNP N/A
- Industry
- ALCE Power Generation
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALCE Utilities
- TTNP Health Care
- Exchange
- ALCE Nasdaq
- TTNP Nasdaq
- Market Cap
- ALCE 3.7M
- TTNP 3.3M
- IPO Year
- ALCE N/A
- TTNP 1996
- Fundamental
- Price
- ALCE $0.80
- TTNP $3.53
- Analyst Decision
- ALCE
- TTNP
- Analyst Count
- ALCE 0
- TTNP 0
- Target Price
- ALCE N/A
- TTNP N/A
- AVG Volume (30 Days)
- ALCE 674.0K
- TTNP 28.0K
- Earning Date
- ALCE 11-19-2024
- TTNP 12-27-2024
- Dividend Yield
- ALCE N/A
- TTNP N/A
- EPS Growth
- ALCE N/A
- TTNP N/A
- EPS
- ALCE N/A
- TTNP N/A
- Revenue
- ALCE N/A
- TTNP $3,000.00
- Revenue This Year
- ALCE N/A
- TTNP N/A
- Revenue Next Year
- ALCE N/A
- TTNP N/A
- P/E Ratio
- ALCE N/A
- TTNP N/A
- Revenue Growth
- ALCE N/A
- TTNP N/A
- 52 Week Low
- ALCE $0.74
- TTNP $3.24
- 52 Week High
- ALCE $162.75
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ALCE 22.06
- TTNP 40.85
- Support Level
- ALCE $0.98
- TTNP $3.25
- Resistance Level
- ALCE $1.23
- TTNP $3.85
- Average True Range (ATR)
- ALCE 0.11
- TTNP 0.36
- MACD
- ALCE 0.02
- TTNP -0.00
- Stochastic Oscillator
- ALCE 4.29
- TTNP 24.76
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.